Johannes Fischer

5PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityInnate immunityGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 07, 2026
First-Line PD-1 Inhibitor-Based Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma: A Revised Systematic Review and Meta-Analysis of Phase III Trials.

|Mar 25, 2026
Immune cell profiling reveals expanded stem cell-like memory T cells in anti-GAD65-associated neurological syndromes.

Sumanta Barman, Saskia Räuber, Katharina Eisenhut

|Apr 22, 2025
Distinct HLA Haplotypes Are Associated With an Altered Strength of SARS-CoV-2-Specific T-Cell Responses and Unfavorable Disease Courses.

C Dörnte, A Datsi, V Traska

|Jul 29, 2023
In Vitro Analysis of the Effect of SARS-CoV-2 Non-VOC and four Variants of Concern on MHC-Class-I Expression on Calu-3 and Caco-2 Cells.

Nora A Bahlmann, Lena Mautner, Mona Hoyos

|Jan 21, 2023
Immunogenetic Predisposition to SARS-CoV-2 Infection.

Claudia Lehmann, Henry Loeffler-Wirth, Vera Balz

Pageof 1

Frequent Collaborators

2 joint publications

Edwin Bölke

1 joint publications

C Dörnte

1 joint publications

Henry Loeffler-Wirth

1 joint publications

Thomas Gruenewald